What are the imaging findings of renal thrombotic microangiopathy (TMA)?

Imaging Findings of Renal Thrombotic Microangiopathy

Renal TMA has limited and nonspecific imaging findings on conventional modalities—the diagnosis is primarily established through renal biopsy showing characteristic histopathologic features, not imaging.

Key Imaging Characteristics

Ultrasound and Conventional Imaging

• Small echogenic kidneys may be seen in chronic cases as part of structural abnormalities 1
• Renal scarring can develop with repeated TMA episodes 1
• Standard ultrasound, CT, and MRI typically show nonspecific findings and cannot reliably diagnose TMA

Advanced Imaging Modalities

Contrast-enhanced ultrasound shows promise for renal TMA evaluation:

• Can provide dynamic quantitative information about renal perfusion 1
• Capable of diagnosing acute cortical necrosis in both native kidneys and allografts 1
• Not nephrotoxic, making it ideal for patients with acute kidney injury 1
• Enables microvascular imaging that may detect perfusion abnormalities

Brain MRI (When Neurological Involvement Suspected)

In the 10-20% of patients with neurological manifestations 2:

• Bilateral and symmetrical hyperintensities of the basal ganglia on FLAIR and T2-weighted sequences are suggestive of TMA 2
• Other affected areas include: cerebral peduncles, caudate nuclei, putamen, thalami, hippocampi, insulae, and brainstem 2
• Brain MRI should be performed when patients present with neurological symptoms, motor deficits, vision changes, seizures, or encephalopathy 2

Critical Clinical Context

Why Imaging is Limited

The diagnosis of renal TMA fundamentally relies on histopathologic examination, not imaging 3, 4, 5:

• Renal biopsy reveals characteristic findings: schistocytes in tubules, tubular necrosis, fibrin deposits in arterioles/interlobular arteries, vascular wall sclerosis, and the pathognomonic "onion-skin" lesion 3, 6
• Renal-limited TMA can occur without systemic features (no schistocytes, thrombocytopenia, or hemolysis on labs), making imaging even less useful 4, 5
• Studies show that malignant hypertension and lupus-associated TMA often present as "isolated renal TMA" without systemic markers 5

Important Caveats

• Early biopsy is essential when TMA is suspected, as delayed diagnosis can lead to irreversible renal damage and dialysis dependence 3, 4
• Absence of systemic features does not exclude TMA—careful histopathologic evaluation is mandatory even when schistocytes are absent 2, 4, 5
• In transplant recipients, electron microscopy may help identify antibody-mediated rejection-associated TMA 7, 8

Practical Algorithm

When evaluating suspected renal TMA:

1. Do not rely on imaging for diagnosis—proceed directly to renal biopsy if clinical suspicion exists
2. Consider contrast-enhanced ultrasound if available to assess renal perfusion and cortical necrosis 1
3. Order brain MRI only if neurological symptoms are present 2
4. Recognize that structural changes (small echogenic kidneys, scarring) represent chronic damage, not acute TMA 1

The bottom line: Imaging plays a minimal diagnostic role in renal TMA. Renal biopsy remains the gold standard, and clinicians should not delay biopsy waiting for imaging findings that will likely be nonspecific or absent.